Advanced / Loading Phase (Optional)
Some protocols use a higher TB-500 loading dose during the first 2–4 weeks based on clinical monograph recommendations[5]. This schedule uses higher total blend volumes.
Route: measurement | Frequency: Once daily or split twice weekly for TB-500 loading
| Phase |
Example amount (total blend) |
Per-Peptide Dose |
Units (mL) |
| Loading (Weeks 1–4) |
1,500 mcg (1.5 mg) |
~750 mcg each |
22.5 units (0.225 mL) |
| Maintenance (Weeks 5–8) |
1,000 mcg (1.0 mg) |
~500 mcg each |
15 units (0.15 mL) |
Note: Advanced protocols consume peptide supplies faster. Plan vial quantities accordingly.
Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.
How This Works
BPC-157 is a synthetic pentadecapeptide (15 amino acids) originally isolated from human gastric juice. Preclinical research indicates it exerts cytoprotective effects across multiple organ systems, promotes angiogenesis, modulates nitric oxide pathways, and interacts with growth-factor systems involved in tissue repair[1][2]. TB-500 (Thymosin β4) is a naturally occurring peptide that regulates actin polymerization, promotes cell migration, reduces inflammation, and supports wound healing and tissue regeneration[3][4]. The combination is hypothesized to provide complementary mechanisms for accelerated musculoskeletal and soft-tissue recovery.
References
Biomedicines (2022)
— Stable gastric pentadecapeptide BPC 157: pleiotropic beneficial activity and neurotransmitter interactions
Current Pharmaceutical Design (2018)
— BPC 157 and standard angiogenic growth factors: gastrointestinal tract healing and angiogenesis
Annals of the New York Academy of Sciences (2007)
— Thymosin β4: roles in development, repair, and regeneration
Expert Opinion on Biological Research (2018)
— Thymosin β4: a multi-functional regenerative peptide; basic mechanisms and clinical applications
American Academy of Anti-Aging Medicine
— Thymosin beta 4 (Tb4) professional monograph (indications, measurement)
View Source
Bachem Technical Note
— Peptide stability and handling guidelines
International Journal of Clinical Pharmacy (2013)
— Evaluation of maximum beyond-use-date stability of peptide solutions
CDC
— Vaccine preparation: route (angle, site rotation guidance)
WADA Prohibited List (2024)
— Growth factors and peptides prohibited in sport
Arthroscopy (2025)
— Emerging use of BPC-157 in orthopaedic sports medicine: a systematic review
PubMed (2010)
— Randomized, placebo-controlled, single and multiple dose study of intravenous thymosin beta4 in healthy volunteers
CDC (Subcut Measurement PDF)
— Technique diagram and site guidance for measurements
NCBI Bookshelf
— Preparation of parenteral medications: best practices
Drug Measurement Review (PMC)
— Pharmacologic considerations of the route
